Dr. Muneto Mogi is the Global Head of Chemistry at Novartis Biomedical Research, where he has worked in various executive leadership and senior research discovery positions in chemistry over nearly 30 years across global organizations in USA, Japan, Germany, and Switzerland. He has contributed over 60 drug discovery projects in different therapeutic areas using various modalities, such as small molecules, peptides, chemical biology conjugates, biomaterials, and polymers. Currently based in Cambridge, Massachusetts USA, he oversees Novartis’s discovery chemistry worldwide, which covers diverse disease areas such as oncology, cardiovascular and metabolism, neuroscience, and immunology. Before joining Novartis, he worked at Shionogi and Bayer Healthcare in Japan. Dr. Mogi obtained his BA in Chemistry from Boston University and received his Ph.D. in Pharmaceutical Sciences from Kyoto Pharmaceutical University.